CURE LEUKAEMIA
Latest income
£2.9m
Latest spending
£2.9m
Registered
2003
Accounts read
FY2024
Financial health, per its FY2024 accounts
The accounts state that the charity achieved a net surplus of £28,899 for the year ended 31 October 2024, with total unrestricted funds carried forward amounting to £457,790. The trustees consider the present level of funding to be adequate to support the continuation of existing activities and the development of future running expenses. The auditors confirmed that the use of the going concern basis of accounting is appropriate with no material uncertainties identified.
What the accounts disclose
Reserves policy: between 6 and 12 months unrestricted expenditure (held: £458k)
“The charity would like to maintain unrestricted funds not committed or invested in tangible fixed assets, which are the free reserves of the charity, at a level which equates to between 6 and 12 months unrestricted expenditure.” — page 6
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Grant paid to Accelerating Clinical Trials Limited, where two trustees are directors. Outstanding balance of £275,000.
“During the year ended 31 October 2024 an amount of £740,000 (2023: £728,193) was paid by the charity to Accelerating Clinical Trials Limited in respect of grants to fund leukaemia research. As at 31 October 2024 an amount of £275,000 (2023: £Nil) remained due to Accelerating Clinical Trials Limited from the charity.” — page 34
“During the year ended 31 October 2024 the charity incurred charges totalling £16,770 (2023: £14,370) from Clover HR Services Limited for HR and other governance work which were provided under normal commercial terms.” — page 34
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Charges of £16,770 paid to Clover HR Services Limited, where trustee M Doolin is a director.
“During the year ended 31 October 2024 an amount of £740,000 (2023: £728,193) was paid by the charity to Accelerating Clinical Trials Limited in respect of grants to fund leukaemia research. As at 31 October 2024 an amount of £275,000 (2023: £Nil) remained due to Accelerating Clinical Trials Limited from the charity.” — page 34
“During the year ended 31 October 2024 the charity incurred charges totalling £16,770 (2023: £14,370) from Clover HR Services Limited for HR and other governance work which were provided under normal commercial terms.” — page 34
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Payment of £4,186 to I Craddock, daughter of trustee C F Craddock, for services.
“During the year ended 31 October 2024 an amount of £740,000 (2023: £728,193) was paid by the charity to Accelerating Clinical Trials Limited in respect of grants to fund leukaemia research. As at 31 October 2024 an amount of £275,000 (2023: £Nil) remained due to Accelerating Clinical Trials Limited from the charity.” — page 34
“During the year ended 31 October 2024 the charity incurred charges totalling £16,770 (2023: £14,370) from Clover HR Services Limited for HR and other governance work which were provided under normal commercial terms.” — page 34
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Charges of £2,263 paid to Silks Solicitors Limited, where company secretary K A H Jones is a partner/director.
“During the year ended 31 October 2024 an amount of £740,000 (2023: £728,193) was paid by the charity to Accelerating Clinical Trials Limited in respect of grants to fund leukaemia research. As at 31 October 2024 an amount of £275,000 (2023: £Nil) remained due to Accelerating Clinical Trials Limited from the charity.” — page 34
“During the year ended 31 October 2024 the charity incurred charges totalling £16,770 (2023: £14,370) from Clover HR Services Limited for HR and other governance work which were provided under normal commercial terms.” — page 34
Per its FY2024 accounts as filed with the Charity Commission.
Governance: Reported Incident: Misappropriation of funds by a former employee was uncovered and reported to the police.
“A misappropriation of funds by a former employee was uncovered and reported to the police and investigated by the police and the charity in accordance with police advice.” — page 6
Per its FY2024 accounts as filed with the Charity Commission.
Structured financials (annual return, FY ending 31/10/2024)
Total income
£2.9m
Total spending
£2.9m
Cost of raising funds
£2.3m
Reserves (reported)
£458k
Employees
9
Trustees
- Alston Owens
- DR Guy Edward Dickens Pratt
- Dr Priyanka Mehta
- Geoffrey William Cousins
- Joanne Claire Murphy
- Laura Manning Shoaf CBE
- PROFESSOR CHARLES FRANK CRADDOCK
- Philip Mark Whitehead
- Sarah Margaret Hope
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/10/2024 | £2.9m | £2.9m |
| 31/10/2023 | £2.9m | £3.0m |
| 31/10/2022 | £2.7m | £2.3m |
| 31/10/2021 | £2.3m | £2.3m |
| 31/10/2020 | £329k | £509k |
Common questions
Is CURE LEUKAEMIA financially healthy?
The accounts state that the charity achieved a net surplus of £28,899 for the year ended 31 October 2024, with total unrestricted funds carried forward amounting to £457,790. The trustees consider the present level of funding to be adequate to support the continuation of existing activities and the development of future running expenses. The auditors confirmed that the use of the going concern basis of accounting is appropriate with no material uncertainties identified. Its FY2024 accounts were audited by J W Hinks LLP.
Who funds CURE LEUKAEMIA?
Funders whose own accounts filings name CURE LEUKAEMIA as a grant recipient include THE PENNIES FOUNDATION, BNA CHARITABLE INCORPORATED ORGANISATION, THE ROAN CHARITABLE TRUST, FARRER AND CO CHARITABLE TRUST.
Known funders
| Funder | Year | Amount |
|---|---|---|
| THE PENNIES FOUNDATION | FY2024 | £44k |
| BNA CHARITABLE INCORPORATED ORGANISATION | FY2023 | £25k |
| THE ROAN CHARITABLE TRUST | FY2022 | £10k |
| FARRER AND CO CHARITABLE TRUST | FY2025 | £4k |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE PIERREPONT TRUST | 2 | £40k |
| SALOMAN FOUNDATION | 1 | — |
| THE FRANCES AND AUGUSTUS NEWMAN FOUNDATION | 1 | £176k |
| CHILDREN WITH CANCER UK | 1 | £125k |
| DAVID & RUTH LEWIS FAMILY CHARITABLE TRUST | 1 | £55k |
| OGLESBY CHARITABLE TRUST | 1 | £50k |
| THE EMMANUEL KAYE FOUNDATION | 1 | £45k |
| THE GEORGE GOODSIR CHARITABLE TRUST | 1 | £25k |